English
简体中文
Total: £ 56.28
Published Date: 2026-02-05 | Pages: 127 | Tables: 119 | Medical Devices & Consumables
The global Drug Microneedle Patches market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug Microneedle Patches competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Drug microneedle patches are an innovative drug delivery system that uses tiny, needle-like projections to administer medications through the skin. These patches are similar in design to vaccine microneedle patches but are used for delivering various drugs. The microneedles can be designed to either dissolve after penetrating the skin, releasing the drug, or they can be coated with the drug, which then diffuses into the skin as the microneedles remain in place. Drugs delivered through the skin can bypass the digestive system, avoiding issues like drug degradation in the stomach or liver and allowing for better absorption.
The North American market for Drug Microneedle Patches is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Drug Microneedle Patches is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Drug Microneedle Patches include CosMED Pharmaceutical, Raphas, Micron Biomedical, VaxessTechnologies, WCC Biomedical, Shenzhen Qinglan Biotechnology, Zhuhai Youwe Biotechnology, Nantong Weizhen Pharmaceutical, Guangzhou Novaken Pharmaceutical, Beijing CAS Microneedle Technology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Drug Microneedle Patches market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Microneedle Patches. The Drug Microneedle Patches market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug Microneedle Patches market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Microneedle Patches manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CosMED Pharmaceutical
Raphas
Micron Biomedical
VaxessTechnologies
WCC Biomedical
Shenzhen Qinglan Biotechnology
Zhuhai Youwe Biotechnology
Nantong Weizhen Pharmaceutical
Guangzhou Novaken Pharmaceutical
Beijing CAS Microneedle Technology
Anodyne Nanotech
Harro Höfliger
Wuhan Tianshiwei
Segment by Type
Dissolving Microneedles
Solid Microneedles
Others
by Application
Hospitals
Beauty Institutions
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Drug Microneedle Patches manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Drug Microneedle Patches sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Drug Microneedle Patches Market Overview
1.1 Product Definition
1.2 Drug Microneedle Patches by Type
1.2.1 Global Drug Microneedle Patches Market Value by Type: 2025 vs 2032
1.2.2 Dissolving Microneedles
1.2.3 Solid Microneedles
1.2.4 Others
1.3 Drug Microneedle Patches by Application
1.3.1 Global Drug Microneedle Patches Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Beauty Institutions
1.3.4 Others
1.4 Global Drug Microneedle Patches Market Size Estimates and Forecasts
1.4.1 Global Drug Microneedle Patches Revenue 2021–2032
1.4.2 Global Drug Microneedle Patches Sales 2021–2032
1.4.3 Global Drug Microneedle Patches Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Drug Microneedle Patches Market Competition by Manufacturers
2.1 Global Drug Microneedle Patches Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drug Microneedle Patches Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drug Microneedle Patches Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drug Microneedle Patches, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drug Microneedle Patches, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drug Microneedle Patches, Product Types and Applications
2.7 Global Key Manufacturers of Drug Microneedle Patches, Date of Entry into the Industry
2.8 Global Drug Microneedle Patches Market Competitive Situation and Trends
2.8.1 Global Drug Microneedle Patches Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drug Microneedle Patches Players Market Share by Revenue
2.8.3 Global Drug Microneedle Patches Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Microneedle Patches Market Scenario by Region
3.1 Global Drug Microneedle Patches Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drug Microneedle Patches Sales by Region: 2021–2032
3.2.1 Global Drug Microneedle Patches Sales by Region: 2021–2026
3.2.2 Global Drug Microneedle Patches Sales by Region: 2027–2032
3.3 Global Drug Microneedle Patches Revenue by Region: 2021–2032
3.3.1 Global Drug Microneedle Patches Revenue by Region: 2021–2026
3.3.2 Global Drug Microneedle Patches Revenue by Region: 2027–2032
3.4 North America Drug Microneedle Patches Market Facts & Figures by Country
3.4.1 North America Drug Microneedle Patches Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drug Microneedle Patches Sales by Country (2021–2032)
3.4.3 North America Drug Microneedle Patches Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Microneedle Patches Market Facts & Figures by Country
3.5.1 Europe Drug Microneedle Patches Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drug Microneedle Patches Sales by Country (2021–2032)
3.5.3 Europe Drug Microneedle Patches Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Microneedle Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Microneedle Patches Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drug Microneedle Patches Sales by Region (2021–2032)
3.6.3 Asia Pacific Drug Microneedle Patches Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Microneedle Patches Market Facts & Figures by Country
3.7.1 Latin America Drug Microneedle Patches Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drug Microneedle Patches Sales by Country (2021–2032)
3.7.3 Latin America Drug Microneedle Patches Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Microneedle Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Microneedle Patches Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drug Microneedle Patches Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drug Microneedle Patches Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Microneedle Patches Sales by Type (2021–2032)
4.1.1 Global Drug Microneedle Patches Sales by Type (2021–2026)
4.1.2 Global Drug Microneedle Patches Sales by Type (2027–2032)
4.1.3 Global Drug Microneedle Patches Sales Market Share by Type (2021–2032)
4.2 Global Drug Microneedle Patches Revenue by Type (2021–2032)
4.2.1 Global Drug Microneedle Patches Revenue by Type (2021–2026)
4.2.2 Global Drug Microneedle Patches Revenue by Type (2027–2032)
4.2.3 Global Drug Microneedle Patches Revenue Market Share by Type (2021–2032)
4.3 Global Drug Microneedle Patches Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drug Microneedle Patches Sales by Application (2021–2032)
5.1.1 Global Drug Microneedle Patches Sales by Application (2021–2026)
5.1.2 Global Drug Microneedle Patches Sales by Application (2027–2032)
5.1.3 Global Drug Microneedle Patches Sales Market Share by Application (2021–2032)
5.2 Global Drug Microneedle Patches Revenue by Application (2021–2032)
5.2.1 Global Drug Microneedle Patches Revenue by Application (2021–2026)
5.2.2 Global Drug Microneedle Patches Revenue by Application (2027–2032)
5.2.3 Global Drug Microneedle Patches Revenue Market Share by Application (2021–2032)
5.3 Global Drug Microneedle Patches Price by Application (2021–2032)
6 Key Companies Profiled
6.1 CosMED Pharmaceutical
6.1.1 CosMED Pharmaceutical Company Information
6.1.2 CosMED Pharmaceutical Description and Business Overview
6.1.3 CosMED Pharmaceutical Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 CosMED Pharmaceutical Drug Microneedle Patches Product Portfolio
6.1.5 CosMED Pharmaceutical Recent Developments/Updates
6.2 Raphas
6.2.1 Raphas Company Information
6.2.2 Raphas Description and Business Overview
6.2.3 Raphas Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Raphas Drug Microneedle Patches Product Portfolio
6.2.5 Raphas Recent Developments/Updates
6.3 Micron Biomedical
6.3.1 Micron Biomedical Company Information
6.3.2 Micron Biomedical Description and Business Overview
6.3.3 Micron Biomedical Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Micron Biomedical Drug Microneedle Patches Product Portfolio
6.3.5 Micron Biomedical Recent Developments/Updates
6.4 VaxessTechnologies
6.4.1 VaxessTechnologies Company Information
6.4.2 VaxessTechnologies Description and Business Overview
6.4.3 VaxessTechnologies Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 VaxessTechnologies Drug Microneedle Patches Product Portfolio
6.4.5 VaxessTechnologies Recent Developments/Updates
6.5 WCC Biomedical
6.5.1 WCC Biomedical Company Information
6.5.2 WCC Biomedical Description and Business Overview
6.5.3 WCC Biomedical Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 WCC Biomedical Drug Microneedle Patches Product Portfolio
6.5.5 WCC Biomedical Recent Developments/Updates
6.6 Shenzhen Qinglan Biotechnology
6.6.1 Shenzhen Qinglan Biotechnology Company Information
6.6.2 Shenzhen Qinglan Biotechnology Description and Business Overview
6.6.3 Shenzhen Qinglan Biotechnology Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shenzhen Qinglan Biotechnology Drug Microneedle Patches Product Portfolio
6.6.5 Shenzhen Qinglan Biotechnology Recent Developments/Updates
6.7 Zhuhai Youwe Biotechnology
6.7.1 Zhuhai Youwe Biotechnology Company Information
6.7.2 Zhuhai Youwe Biotechnology Description and Business Overview
6.7.3 Zhuhai Youwe Biotechnology Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Zhuhai Youwe Biotechnology Drug Microneedle Patches Product Portfolio
6.7.5 Zhuhai Youwe Biotechnology Recent Developments/Updates
6.8 Nantong Weizhen Pharmaceutical
6.8.1 Nantong Weizhen Pharmaceutical Company Information
6.8.2 Nantong Weizhen Pharmaceutical Description and Business Overview
6.8.3 Nantong Weizhen Pharmaceutical Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Nantong Weizhen Pharmaceutical Drug Microneedle Patches Product Portfolio
6.8.5 Nantong Weizhen Pharmaceutical Recent Developments/Updates
6.9 Guangzhou Novaken Pharmaceutical
6.9.1 Guangzhou Novaken Pharmaceutical Company Information
6.9.2 Guangzhou Novaken Pharmaceutical Description and Business Overview
6.9.3 Guangzhou Novaken Pharmaceutical Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Guangzhou Novaken Pharmaceutical Drug Microneedle Patches Product Portfolio
6.9.5 Guangzhou Novaken Pharmaceutical Recent Developments/Updates
6.10 Beijing CAS Microneedle Technology
6.10.1 Beijing CAS Microneedle Technology Company Information
6.10.2 Beijing CAS Microneedle Technology Description and Business Overview
6.10.3 Beijing CAS Microneedle Technology Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Beijing CAS Microneedle Technology Drug Microneedle Patches Product Portfolio
6.10.5 Beijing CAS Microneedle Technology Recent Developments/Updates
6.11 Anodyne Nanotech
6.11.1 Anodyne Nanotech Company Information
6.11.2 Anodyne Nanotech Description and Business Overview
6.11.3 Anodyne Nanotech Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Anodyne Nanotech Drug Microneedle Patches Product Portfolio
6.11.5 Anodyne Nanotech Recent Developments/Updates
6.12 Harro Höfliger
6.12.1 Harro Höfliger Company Information
6.12.2 Harro Höfliger Description and Business Overview
6.12.3 Harro Höfliger Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Harro Höfliger Drug Microneedle Patches Product Portfolio
6.12.5 Harro Höfliger Recent Developments/Updates
6.13 Wuhan Tianshiwei
6.13.1 Wuhan Tianshiwei Company Information
6.13.2 Wuhan Tianshiwei Description and Business Overview
6.13.3 Wuhan Tianshiwei Drug Microneedle Patches Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Wuhan Tianshiwei Drug Microneedle Patches Product Portfolio
6.13.5 Wuhan Tianshiwei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Microneedle Patches Industry Chain Analysis
7.2 Drug Microneedle Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Microneedle Patches Production Mode & Process Analysis
7.4 Drug Microneedle Patches Sales and Marketing
7.4.1 Drug Microneedle Patches Sales Channels
7.4.2 Drug Microneedle Patches Distributors
7.5 Drug Microneedle Patches Customer Analysis
8 Drug Microneedle Patches Market Dynamics
8.1 Drug Microneedle Patches Industry Trends
8.2 Drug Microneedle Patches Market Drivers
8.3 Drug Microneedle Patches Market Challenges
8.4 Drug Microneedle Patches Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Drug Microneedle Patches Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Drug Microneedle Patches Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Drug Microneedle Patches Market Competitive Situation by Manufacturers in 2025
Table 4. Global Drug Microneedle Patches Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Drug Microneedle Patches Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Drug Microneedle Patches Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Drug Microneedle Patches Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Drug Microneedle Patches Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Drug Microneedle Patches, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Drug Microneedle Patches, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Drug Microneedle Patches, Product Types and Applications
Table 12. Global Key Manufacturers of Drug Microneedle Patches, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Microneedle Patches Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Microneedle Patches Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Microneedle Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Drug Microneedle Patches Sales by Region (K Units), 2021–2026
Table 18. Global Drug Microneedle Patches Sales Market Share by Region (2021–2026)
Table 19. Global Drug Microneedle Patches Sales by Region (K Units), 2027–2032
Table 20. Global Drug Microneedle Patches Sales Market Share by Region (2027–2032)
Table 21. Global Drug Microneedle Patches Revenue by Region (US$ Million), 2021–2026
Table 22. Global Drug Microneedle Patches Revenue Market Share by Region (2021–2026)
Table 23. Global Drug Microneedle Patches Revenue by Region (US$ Million), 2027–2032
Table 24. Global Drug Microneedle Patches Revenue Market Share by Region (2027–2032)
Table 25. North America Drug Microneedle Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Drug Microneedle Patches Sales by Country (K Units), 2021–2026
Table 27. North America Drug Microneedle Patches Sales by Country (K Units), 2027–2032
Table 28. North America Drug Microneedle Patches Revenue by Country (US$ Million), 2021–2026
Table 29. North America Drug Microneedle Patches Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Drug Microneedle Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Drug Microneedle Patches Sales by Country (K Units), 2021–2026
Table 32. Europe Drug Microneedle Patches Sales by Country (K Units), 2027–2032
Table 33. Europe Drug Microneedle Patches Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Drug Microneedle Patches Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Drug Microneedle Patches Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Drug Microneedle Patches Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Drug Microneedle Patches Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Drug Microneedle Patches Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Drug Microneedle Patches Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Drug Microneedle Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Drug Microneedle Patches Sales by Country (K Units), 2021–2026
Table 42. Latin America Drug Microneedle Patches Sales by Country (K Units), 2027–2032
Table 43. Latin America Drug Microneedle Patches Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Drug Microneedle Patches Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Drug Microneedle Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Drug Microneedle Patches Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Drug Microneedle Patches Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Drug Microneedle Patches Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Drug Microneedle Patches Revenue by Country (US$ Million), 2027–2032
Table 50. Global Drug Microneedle Patches Sales (K Units) by Type (2021–2026)
Table 51. Global Drug Microneedle Patches Sales (K Units) by Type (2027–2032)
Table 52. Global Drug Microneedle Patches Sales Market Share by Type (2021–2026)
Table 53. Global Drug Microneedle Patches Sales Market Share by Type (2027–2032)
Table 54. Global Drug Microneedle Patches Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Drug Microneedle Patches Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Drug Microneedle Patches Revenue Market Share by Type (2021–2026)
Table 57. Global Drug Microneedle Patches Revenue Market Share by Type (2027–2032)
Table 58. Global Drug Microneedle Patches Price (US$/Unit) by Type (2021–2026)
Table 59. Global Drug Microneedle Patches Price (US$/Unit) by Type (2027–2032)
Table 60. Global Drug Microneedle Patches Sales (K Units) by Application (2021–2026)
Table 61. Global Drug Microneedle Patches Sales (K Units) by Application (2027–2032)
Table 62. Global Drug Microneedle Patches Sales Market Share by Application (2021–2026)
Table 63. Global Drug Microneedle Patches Sales Market Share by Application (2027–2032)
Table 64. Global Drug Microneedle Patches Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Drug Microneedle Patches Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Drug Microneedle Patches Revenue Market Share by Application (2021–2026)
Table 67. Global Drug Microneedle Patches Revenue Market Share by Application (2027–2032)
Table 68. Global Drug Microneedle Patches Price (US$/Unit) by Application (2021–2026)
Table 69. Global Drug Microneedle Patches Price (US$/Unit) by Application (2027–2032)
Table 70. CosMED Pharmaceutical Company Information
Table 71. CosMED Pharmaceutical Description and Business Overview
Table 72. CosMED Pharmaceutical Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. CosMED Pharmaceutical Drug Microneedle Patches Product
Table 74. CosMED Pharmaceutical Recent Developments/Updates
Table 75. Raphas Company Information
Table 76. Raphas Description and Business Overview
Table 77. Raphas Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Raphas Drug Microneedle Patches Product
Table 79. Raphas Recent Developments/Updates
Table 80. Micron Biomedical Company Information
Table 81. Micron Biomedical Description and Business Overview
Table 82. Micron Biomedical Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Micron Biomedical Drug Microneedle Patches Product
Table 84. Micron Biomedical Recent Developments/Updates
Table 85. VaxessTechnologies Company Information
Table 86. VaxessTechnologies Description and Business Overview
Table 87. VaxessTechnologies Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. VaxessTechnologies Drug Microneedle Patches Product
Table 89. VaxessTechnologies Recent Developments/Updates
Table 90. WCC Biomedical Company Information
Table 91. WCC Biomedical Description and Business Overview
Table 92. WCC Biomedical Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. WCC Biomedical Drug Microneedle Patches Product
Table 94. WCC Biomedical Recent Developments/Updates
Table 95. Shenzhen Qinglan Biotechnology Company Information
Table 96. Shenzhen Qinglan Biotechnology Description and Business Overview
Table 97. Shenzhen Qinglan Biotechnology Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Shenzhen Qinglan Biotechnology Drug Microneedle Patches Product
Table 99. Shenzhen Qinglan Biotechnology Recent Developments/Updates
Table 100. Zhuhai Youwe Biotechnology Company Information
Table 101. Zhuhai Youwe Biotechnology Description and Business Overview
Table 102. Zhuhai Youwe Biotechnology Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Zhuhai Youwe Biotechnology Drug Microneedle Patches Product
Table 104. Zhuhai Youwe Biotechnology Recent Developments/Updates
Table 105. Nantong Weizhen Pharmaceutical Company Information
Table 106. Nantong Weizhen Pharmaceutical Description and Business Overview
Table 107. Nantong Weizhen Pharmaceutical Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Nantong Weizhen Pharmaceutical Drug Microneedle Patches Product
Table 109. Nantong Weizhen Pharmaceutical Recent Developments/Updates
Table 110. Guangzhou Novaken Pharmaceutical Company Information
Table 111. Guangzhou Novaken Pharmaceutical Description and Business Overview
Table 112. Guangzhou Novaken Pharmaceutical Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Guangzhou Novaken Pharmaceutical Drug Microneedle Patches Product
Table 114. Guangzhou Novaken Pharmaceutical Recent Developments/Updates
Table 115. Beijing CAS Microneedle Technology Company Information
Table 116. Beijing CAS Microneedle Technology Description and Business Overview
Table 117. Beijing CAS Microneedle Technology Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Beijing CAS Microneedle Technology Drug Microneedle Patches Product
Table 119. Beijing CAS Microneedle Technology Recent Developments/Updates
Table 120. Anodyne Nanotech Company Information
Table 121. Anodyne Nanotech Description and Business Overview
Table 122. Anodyne Nanotech Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Anodyne Nanotech Drug Microneedle Patches Product
Table 124. Anodyne Nanotech Recent Developments/Updates
Table 125. Harro Höfliger Company Information
Table 126. Harro Höfliger Description and Business Overview
Table 127. Harro Höfliger Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Harro Höfliger Drug Microneedle Patches Product
Table 129. Harro Höfliger Recent Developments/Updates
Table 130. Wuhan Tianshiwei Company Information
Table 131. Wuhan Tianshiwei Description and Business Overview
Table 132. Wuhan Tianshiwei Drug Microneedle Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Wuhan Tianshiwei Drug Microneedle Patches Product
Table 134. Wuhan Tianshiwei Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Drug Microneedle Patches Distributors List
Table 138. Drug Microneedle Patches Customers List
Table 139. Drug Microneedle Patches Market Trends
Table 140. Drug Microneedle Patches Market Drivers
Table 141. Drug Microneedle Patches Market Challenges
Table 142. Drug Microneedle Patches Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug Microneedle Patches
Figure 2. Global Drug Microneedle Patches Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Drug Microneedle Patches Market Share by Type: 2025 & 2032
Figure 4. Dissolving Microneedles Product Picture
Figure 5. Solid Microneedles Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug Microneedle Patches Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Drug Microneedle Patches Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Beauty Institutions
Figure 11. Others
Figure 12. Global Drug Microneedle Patches Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Drug Microneedle Patches Market Size (US$ Million), 2021–2032
Figure 14. Global Drug Microneedle Patches Sales (K Units), 2021–2032
Figure 15. Global Drug Microneedle Patches Average Price (US$/Unit), 2021–2032
Figure 16. Drug Microneedle Patches Report Years Considered
Figure 17. Drug Microneedle Patches Sales Share by Manufacturers in 2025
Figure 18. Global Drug Microneedle Patches Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Drug Microneedle Patches Players: Market Share by Revenue in Drug Microneedle Patches in 2025
Figure 20. Drug Microneedle Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Drug Microneedle Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Drug Microneedle Patches Sales Market Share by Country (2021–2032)
Figure 23. North America Drug Microneedle Patches Revenue Market Share by Country (2021–2032)
Figure 24. United States Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Drug Microneedle Patches Sales Market Share by Country (2021–2032)
Figure 27. Europe Drug Microneedle Patches Revenue Market Share by Country (2021–2032)
Figure 28. Germany Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Drug Microneedle Patches Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Drug Microneedle Patches Revenue Market Share by Region (2021–2032)
Figure 35. China Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Drug Microneedle Patches Sales Market Share by Country (2021–2032)
Figure 43. Latin America Drug Microneedle Patches Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Drug Microneedle Patches Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Drug Microneedle Patches Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Drug Microneedle Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Drug Microneedle Patches by Type (2021–2032)
Figure 54. Global Revenue Market Share of Drug Microneedle Patches by Type (2021–2032)
Figure 55. Global Drug Microneedle Patches Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Drug Microneedle Patches by Application (2021–2032)
Figure 57. Global Revenue Market Share of Drug Microneedle Patches by Application (2021–2032)
Figure 58. Global Drug Microneedle Patches Price (US$/Unit) by Application (2021–2032)
Figure 59. Drug Microneedle Patches Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
